astria therapeutics glp-1 receptor agonist weight management diabetes treatments Advances in agonists delivery systems for obesity and GLP-1 Agonists for Weight Loss:
Description
Molecular mechanisms underlying the impact of GLP-1RAs on cancer risk The regulation of cancer risk by GLP-1RAs involves several biological mechanisms, primarily encompassing metabolic regulation, direct anti-tumor effects, immune modulation, and epigenetic alterations
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications
The role of tumor necrosis factor-alpha in the pathogenesis and treatment of nonalcoholic fatty liver disease
Weight loss drugs are prescribed to individuals with obesity or individuals who are overweight and managing a weight-related health condition
What are the side effects
